Drug intelligence / Profile preview

BLB-201

Development stage: Phase 2
Lead developer: Blue Lake Biotechnology
Modality: Viral Vectors → Gene Addition/Replacement → Gene Therapies, Vaccines & Immunotherapeutics
Administration: Intranasal

Overview

BLB-201 is an investigational intranasal vaccine candidate developed for the prevention of respiratory syncytial virus (RSV) infection. It is based on a proprietary parainfluenza virus 5 (PIV5) vector that encodes the RSV F protein. The PIV5 vector is not known to cause disease in humans and has been used safely in veterinary vaccines for decades. BLB-201 aims to induce both antibody and cell-mediated immune responses against RSV, with preclinical studies showing immunogenicity and protection from RSV infection in animal models. Clinical trials have demonstrated safety, tolerability, and promising immunogenicity in infants, young children, and adults over 60 years old. The vaccine is administered as a single intranasal dose.

Other names: recombinant parainfluenza virus type 5 expressing RSV F protein

Targets

RSV F (Respiratory syncytial virus fusion protein)

Beyond the preview

Go deeper on BLB-201.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BLB-201.

Explore the full profile